ACHV US Equity
Achieve Life Sciences, Inc.Health Care · In Vitro & In Vivo Diagnostic Substances · CIK 949858 · FY ends Dec 31$8.53
+1.01 (+13.43%)
USD · as of 2026-08-19 · marketstack
Short interest· FINRA consolidated · settlement 2026-07-31
6 settlement cycles| Shares short | 16.3M |
| % of shares out | 15.8% |
| Days to cover | 15.0 |
| Δ vs 2026-07-15 | +10.5% |
bars = shares short · line = days to cover (own scale)
| Settlement | Shares short | Δ vs prior | Avg daily volume | Days to cover |
|---|
| 2026-07-31 | 16,273,408 | +10.5% | 1,082,035 | 15.0 |
| 2026-07-15 | 14,730,069 | +17.1% | 1,895,801 | 7.8 |
| 2026-06-30 | 12,582,151 | +52.9% | 3,787,293 | 3.3 |
| 2026-06-15 | 8,230,908 | +7.2% | 1,359,436 | 6.0 |
| 2026-05-29 | 7,675,144 | +5.9% | 1,407,606 | 5.5 |
| 2026-05-15 | 7,244,501 | +5.1% | 1,285,742 | 5.6 |
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
